Alternative NSN: 6505-01-656-4667 |
Item Name: Fentanyl Transdermal System |
NIIN: 016564667 |
NCB Code: USA (01) |
Manufacturers: Actavis Pharma Inc, Janssen Pharmaceuticals Inc, Mallinckrodt Inc, Mylan Pharmaceuticals Inc, Par Pharmaceutical Inc, Sandoz Inc |
Are you looking for NSN 6505-01-656-4667 - Fentanyl Transdermal System parts? We can help! Simply complete the RFQ form given below to get started. The National Stock Number (NSN) is a 13-digit serial number assigned by the US Defense Logistics Agency (DLA) to items that are procured, stocked, and issued through the federal supply system. Parts under NSN 6505-01-656-4667 is NDC00378-9123-98, NDC00406-9075-76, NDC00591-3213-72, NDC00781-7243-55, NDC49884-0763-78 from manufacturer Mylan Pharmaceuticals Inc, Mallinckrodt Inc, Actavis Pharma Inc, Sandoz Inc, Par Pharmaceutical Inc. Use our optimized search engine to find your required part—then submit an instant RFQ for a quick, competitive quote. Here at Aviation Orbit, we make your purchasing process as simple and efficient as possible.
Part No | Manufacturer | Item Name | QTY | RFQ |
---|---|---|---|---|
NDC00378-9123-98 | Mylan Pharmaceuticals Inc | fentanyl transdermal system | Avl | RFQ |
NDC00406-9075-76 | Mallinckrodt Inc | fentanyl transdermal system | Avl | RFQ |
NDC00591-3213-72 | Actavis Pharma Inc | fentanyl transdermal system | Avl | RFQ |
NDC00781-7243-55 | Sandoz Inc | fentanyl transdermal system | Avl | RFQ |
NDC49884-0763-78 | Par Pharmaceutical Inc | fentanyl transdermal system | Avl | RFQ |
NDC50458-0093-05 | Janssen Pharmaceuticals Inc | fentanyl transdermal system | Avl | RFQ |
MRC | Criteria | Characteristic |
---|---|---|
FEAT | Special Features | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
CSLZ | Usual Dose | 75 MCG/HR |
CBBL | Features Provided | INDIVIDUALLY SEALED |
CRYC | Controlled Substance Classification | SCHEDULE II |
CXCY | Part Name Assigned By Controlling Agency | DURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S |
MRC | Decoded Requirement | Clear Text Reply |
6505-00-004-6658 (6505000046658) |
6505-00-004-6666 (6505000046666) |
6505-00-004-6676 (6505000046676) |
6505-00-005-3940 (6505000053940) |
6505-00-006-3321 (6505000063321) |
6505-00-007-2156 (6505000072156) |
6505-00-007-4529 (6505000074529) |
6505-00-007-4531 (6505000074531) |
6505-00-007-4535 (6505000074535) |
6505-00-007-4538 (6505000074538) |
6505-00-007-8290 (6505000078290) |
6505-00-007-8293 (6505000078293) |
We Hope You Choose Us as Your Low-Price, High-Quality Parts Distributor In the Future.
Request for Quote